Singapore, Sept. 2 -- TELIX PHARMACEUTICALS LIMITED made the following announcement:
Security Name: TELIXPHAR A$650M2.375%N290730
General Announcement::ASX:TLX; NASDAQ:TLX - Telix Completes Enrollment in Phase 3 BiPASS Study (https://links.sgx.com/1.0.0/corporate-announcements/67F7FCQOAUA440ID/bfc355ac4cabd2d04ef758aba252dc62fa8d60788921dbba28f6723b330af8e2)
Published by HT Digital Content Services with permission from South East Asian News....